VFA
AMPE

Valeo Financial Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Valeo Financial Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,112
Closed -$157K – 669
2022
Q1 		$157K Buy
+1,112
New +$162K 0.01% 564
2020
Q1 		– Sell
-1,817
Closed -$318K – 1965
2019
Q4 		$318K Buy
+1,817
New +$235K 0.03% 245
2019
Q3 		– Sell
-1,100
Closed -$128K – 1713
2019
Q2 		$128K Hold
1,100
– – 0.01% 378
2019
Q1 		$185K Hold
1,100
– – 0.02% 294
2018
Q4 		$130K Hold
1,100
– – 0.02% 328
2018
Q3 		$152K Hold
1,100
– – 0.02% 321
2018
Q2 		$155K Buy
+1,100
New +$823K 0.02% 319

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valeo Financial Advisors's AMPE Position: Q2 2022 in Review

Valeo Financial Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 1,112 shares — an estimated $157K sold.

Valeo Financial Advisors first reported a position in AMPE in Q2 2018 and held it in 7 quarters. The position peaked at $318K in Q4 2019. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Valeo Financial Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 1,112 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $157K.
  • Valeo Financial Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 7 quarters.
  • Valeo Financial Advisors's Ampio Pharmaceuticals Inc. position peaked at $318K in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Valeo Financial Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.